A detailed history of Harbor Investment Advisory, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Harbor Investment Advisory, LLC holds 664 shares of DXCM stock, worth $53,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares
664
Previous 952 30.25%
Holding current value
$53,279
Previous $107,000 58.88%
% of portfolio
0.0%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

SELL
$64.0 - $116.06 $18,432 - $33,425
-288 Reduced 30.25%
664 $44,000
Q2 2024

Jul 19, 2024

BUY
$110.31 - $140.45 $9,707 - $12,359
88 Added 10.19%
952 $107,000
Q1 2024

Apr 12, 2024

BUY
$114.22 - $140.1 $11,422 - $14,010
100 Added 13.09%
864 $119,000
Q4 2023

Jan 26, 2024

SELL
$75.49 - $124.16 $47,483 - $78,096
-629 Reduced 45.15%
764 $94,000
Q3 2023

Oct 13, 2023

SELL
$86.06 - $137.93 $90,276 - $144,688
-1,049 Reduced 42.96%
1,393 $129,000
Q2 2023

Jul 14, 2023

SELL
$112.47 - $130.98 $103,922 - $121,025
-924 Reduced 27.45%
2,442 $313,000
Q1 2023

Apr 21, 2023

SELL
$104.0 - $122.92 $6,864 - $8,112
-66 Reduced 1.92%
3,366 $391,000
Q4 2022

Jan 24, 2023

BUY
$84.98 - $122.67 $5,778 - $8,341
68 Added 2.02%
3,432 $0
Q3 2022

Nov 01, 2022

SELL
$76.35 - $94.18 $91,925 - $113,392
-1,204 Reduced 26.36%
3,364 $271,000
Q2 2022

Jul 18, 2022

BUY
$67.99 - $132.89 $241,840 - $472,689
3,557 Added 351.83%
4,568 $340,000
Q1 2022

Apr 20, 2022

BUY
$94.08 - $130.2 $39,984 - $55,334
425 Added 72.53%
1,011 $517,000
Q4 2021

Jan 10, 2022

SELL
$129.87 - $162.82 $24,025 - $30,121
-185 Reduced 23.99%
586 $315,000
Q3 2021

Oct 12, 2021

SELL
$106.71 - $143.18 $40,869 - $54,837
-383 Reduced 33.19%
771 $422,000
Q2 2021

Jul 27, 2021

BUY
$80.99 - $107.93 $14,659 - $19,535
181 Added 18.6%
1,154 $493,000
Q1 2021

Apr 16, 2021

BUY
$84.79 - $104.74 $58,589 - $72,375
691 Added 245.04%
973 $350,000
Q4 2020

Feb 04, 2021

BUY
$78.0 - $104.5 $1,404 - $1,881
18 Added 6.82%
282 $104,000
Q3 2020

Oct 23, 2020

SELL
$95.51 - $112.95 $3,724 - $4,405
-39 Reduced 12.87%
264 $109,000
Q2 2020

Jul 16, 2020

BUY
$62.68 - $105.34 $188 - $316
3 Added 1.0%
303 $123,000
Q1 2020

May 11, 2020

BUY
$47.79 - $75.63 $9,510 - $15,050
199 Added 197.03%
300 $81,000
Q4 2019

Jan 16, 2020

BUY
$36.62 - $57.29 $3,698 - $5,786
101 New
101 $22,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Harbor Investment Advisory, LLC Portfolio

Follow Harbor Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbor Investment Advisory, LLC with notifications on news.